絞り込み

17906

広告

「"Zirlik K "[Author]」の検索結果

44件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Idelalisib.

Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment.

Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab.

Anti-Angiogenics: Current Situation and Future Perspectives.

Drug-perturbation-based stratification of blood cancer.

The microenvironmental stromal cells abrogate NF-κB inhibitor induced apoptosis in chronic lymphocytic leukemia.

Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia.

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.

BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.

Selection patterns of B-cell receptors and the natural history of follicular lymphoma.

From CLL to Multiple Myeloma - Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration.

Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome.

Lectins from opportunistic bacteria interact with acquired variable region glycans of surface Ig in follicular lymphoma.

F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC - a novel mode of kinase inhibitor resistance.

Evidence for idiotype-directed immunosurveillance is restricted to follicular lymphoma and attributable to somatic hypermutation.

BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia.

[Surgical treatment of esophageal cancer : Evolution of management and prognosis over the last 3 decades.]

MDSCs: the final frontier of the microenvironment in CLL?

Multidimensional scaling analysis identifies pathological and prognostically relevant profiles of circulating T-cells in chronic lymphocytic leukemia.

  1. 1
  2. 2
  3. 3
Sort by
※並べ替えは表示に時間がかかります